InsidersTradesSigma
Follow the 持田製薬株式会社 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Market capitalisation: €111.6bn. The latest transaction was disclosed on 10 April 2026 (Holding update). Among the most active insiders: Mochida Memorial Foundation for Medical and Pharmaceutical Research. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Mochida Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, and marketing of drugs. It focuses on therapeutic areas such as dermatology and neurology.